Obstructive sleep apnea prevalence in people with peripheral artery disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a preliminary observational cohort enrolling adults with confirmed peripheral arterial occlusive disease at a single French hospital. Participants who are scheduled for routine sleep polygraphy will have overnight respiratory monitoring and their vascular status recorded, including ankle-brachial index when feasible. The study includes patients at all disease stages and excludes those with a prior polygraphy-confirmed OSAS diagnosis currently on nocturnal therapy. No experimental treatments are given; collected data will be pseudonymized and analyzed to estimate OSAS prevalence in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 18 years
2. Patients with a confirmed diagnosis of PAOD, seen either during hospitalization or in an outpatient vascular medicine consultation. Inclusion is permitted regardless of the disease stage (according to the Leriche and Fontaine classification) or prior surgical intervention.
3. No objection to the use of their pseudonymised medical data
4. Polygraphy scheduled as part of routine care within one month.

Exclusion Criteria:

1. Inability to perform the Ankle-Brachial Index (ABI) or sleep polygraphy due to physical or cognitive constraints (e.g., severe dementia, limb malformation, etc.).
2. History of OSAS diagnosis confirmed by polygraphy, and currently receiving nocturnal treatment (e.g., Continuous Positive Airway Pressure - CPAP)

Where it's running

• Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
  Toulon, Var, France Recruiting

Study contacts

• Study coordinator: Léonie GEY, M.D.
• Email: leonie.gey@ch-toulon.fr
• Phone: 04 94 14 50 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events

  In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.

  Recruiting Phase 4 Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07796217

• Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD

  This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.

  Recruiting Laval University · Lévis, Quebec · NCT07655206

• Super-resolution ultrasound imaging for peripheral artery disease

  This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07374601

• Using wearable activity trackers and a mobile app to help people with peripheral artery disease walk better

  This project will test whether a personalized home walking program guided by wearable activity trackers and automatic feedback can help people with peripheral artery disease walk as well as supervised exercise sessions.

  Recruiting at 2 sites Chinese University of Hong Kong · Hong Kong, Hong Kong and 1 other locations · NCT07012070

• Evaluating a Paclitaxel Coated Balloon for Treating Atherosclerosis in Leg Arteries

  This study is testing a special balloon treatment to see if it can safely improve blood flow and reduce symptoms in people with blocked leg arteries due to peripheral artery disease.

  Recruiting at 2 sites Balton Sp.zo.o. · Chrzanów, Malopolska and 2 other locations · NCT06734221

• Helping people walk better after leg revascularization for peripheral artery disease

  This project will see if adding a home-based walking program or taking nitrate-rich beetroot juice after leg revascularization helps people with peripheral artery disease walk farther and faster.

  Recruiting at 8 sites Phase 3 Northwestern University · Tucson, Arizona and 7 other locations · NCT06686121

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.